外体miRNAs和乳腺癌:一个复杂的治疗学相互关联,具有临床意义
Sayantanee Mukherjee1, Rajib Dhar2, Swathi Jonnalagadda3
1Centre for Nanosciences and Molecular Medicine, Amrita Vishwa Vidyapeetham, Kochi, India.
概括
细胞外囊泡称为外生体,对乳腺癌 (BC) 的早期检测和治疗有希望. 本综述探讨了它们在BC进展中的作用以及作为治疗神经学工具的潜力.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 细胞生物学 细胞生物学
背景情况:
- 乳腺癌 (BC) 是一个主要的全球健康挑战.
- 瘤细胞衍生外体 (TDXs) 显著影响BC进展,调节转移和治疗耐药性等过程.
- 外基因组正在成为癌症发展的关键参与者.
研究的目的:
- 审查外体在乳腺癌中的多方面的作用.
- 突出基于外体的方法在BC查,诊断和治疗中的潜力.
- 通过外体形分析强调精确瘤学的进步.
主要方法:
- 关于乳腺癌外体细胞研究的文献综述.
- 分析TDX组成 (miRNA,蛋白质,脂质) 和它们的功能影响.
- 讨论基于外体体的液体活检和神经学应用.
主要成果:
- TDXs与瘤微环境重塑,免疫抑制,血管生成,转移和耐药性有关.
- 基于外基因组的查为早期BC检测提供了一个解决方案.
- 外体代表了BC治疗和精确瘤学的有前途的工具.
结论:
- 外体细胞在乳腺癌的进展中起着关键作用,并具有早期检测和向治疗的巨大潜力.
- 基于外体细胞的液体活检和单外体细胞的剖析提升了乳腺癌的精确瘤学.
- 对外体解体的进一步研究可能会导致有效和负担得起的乳腺癌管理策略.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
lncRNA - Long Non-coding RNAs
8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
Overview of Exosomes
2.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K


